Wymox 125mg Dry Syrup contains Amoxycillin, a broad-spectrum beta-lactam antibiotic belonging to the penicillin class, effective against a wide range of bacterial infections. It is primarily indicated for the treatment of infections caused by susceptible strains of bacteria, including respiratory tract infections, otitis media, skin and soft tissue infections, urinary tract infections, and dental infections. The dry syrup formulation is designed for pediatric use, facilitating accurate dosing and improved compliance in children who have difficulty swallowing tablets. Upon reconstitution, Wymox 125mg Dry Syrup provides a palatable oral suspension that ensures optimal bioavailability of amoxycillin. The mechanism of action involves inhibition of bacterial cell wall synthesis, leading to cell lysis and death. Wymox is generally well tolerated; however, hypersensitivity reactions, gastrointestinal disturbances such as diarrhea, nausea, and vomiting may occur. It is contraindicated in patients with a history of penicillin allergy. Dosage should be adjusted according to the severity of infection and patient weight, with adherence to prescribed duration to prevent resistance development. Wymox 125mg Dry Syrup should be stored in a cool, dry place and used within the recommended period after reconstitution. Consultation with a healthcare professional is advised before initiating therapy.